University of Aberdeen, Aberdeen.
Eur Respir J. 2014 Apr;43(4):993-1002. doi: 10.1183/09031936.00065013. Epub 2013 Oct 31.
The new Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011 document recommends a combined assessment of chronic obstructive pulmonary disease (COPD) based on current symptoms and future risk. A large database of primary-care COPD patients across the UK was used to determine COPD distribution and characteristics according to the new GOLD classification. 80 general practices provided patients with a Read code diagnosis of COPD. Electronic and hand searches of patient medical records were undertaken, optimising data capture. Data for 9219 COPD patients were collected. For the 6283 patients with both forced expiratory volume in 1 s (FEV1) and modified Medical Research Council scores (mean±sd age 69.2±10.6 years, body mass index 27.3±6.2 kg·m(-2)), GOLD 2011 group distributions were: A (low risk and fewer symptoms) 36.1%, B (low risk and more symptoms) 19.1%, C (high risk and fewer symptoms) 19.6% and D (high risk and more symptoms) 25.3%. This is in contrast with GOLD 2007 stage classification: I (mild) 17.1%, II (moderate) 52.2%, III (severe) 25.5% and IV (very severe) 5.2%. 20% of patients with FEV1 ≥50% predicted had more than two exacerbations in the previous 12 months. 70% of patients with FEV1 <50% pred had fewer than two exacerbations in the previous 12 months. This database, representative of UK primary-care COPD patients, identified greater proportions of patients in the mildest and most severe categories upon comparing 2011 versus 2007 GOLD classifications. Discordance between airflow limitation severity and exacerbation risk was observed.
新的全球倡议慢性阻塞性肺疾病(GOLD)2011 年的文件建议,根据目前的症状和未来的风险,慢性阻塞性肺疾病(COPD)的综合评估。一个大型的英国初级保健 COPD 患者数据库用于根据新的 GOLD 分类确定 COPD 的分布和特征。80 家普通诊所为患者提供了 COPD 的 Read 代码诊断。对患者的病历进行了电子和手动搜索,以优化数据采集。共收集了 9219 例 COPD 患者的数据。对于 6283 例同时具有 1 秒用力呼气量(FEV1)和改良的医学研究理事会评分(平均年龄 69.2±10.6 岁,体重指数 27.3±6.2kg·m(-2))的患者,GOLD 2011 年组分布为:A(低风险和较少症状)36.1%,B(低风险和更多症状)19.1%,C(高风险和较少症状)19.6%和 D(高风险和更多症状)25.3%。这与 GOLD 2007 分期分类形成对比:I(轻度)17.1%,II(中度)52.2%,III(重度)25.5%和 IV(非常严重)5.2%。20%的 FEV1≥50%预测值的患者在过去 12 个月中有两次以上的加重。70%的 FEV1<50%预的患者在过去 12 个月中有两次以下的加重。该数据库代表了英国初级保健 COPD 患者,与 2007 年 GOLD 分类相比,在比较 2011 年与 2011 年的分类时,发现了更多处于最轻度和最严重类别的患者。观察到气流受限严重程度与加重风险之间的不一致。